Key opportunities include outsourced preclinical research, personalized and advanced therapies, specialized disease models, GLP toxicology, AI analytics, integrated services and localized ...
At the close on September 10, 2026, Labcorp stock extended losses after its Investor Day, with shares sliding about 4.3% and finishing near USD 307 on the NYSE. The move came as investors reacted to ...
Labcorp’s Investor Day was scheduled for September 10, with management set to discuss strategy, capital deployment priorities ...
The foundations for broader adoption of GENFIT's NISTM Technology will progressively strengthen in the coming months, with expanding reimbursement, increasing incorporation into clinical guidelines, ...
Labcorp said Tuesday it has acquired MLM Medical Labs to add global central laboratory and biomarker capabilities for clinical trials. MLM is a global central and specialty laboratory provider with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results